Schiff, Gluckman Earn another Patent for Controlling Seizures
Posted: April 13, 2005 at 1:00 am, Last Updated: November 30, -0001 at 12:00 am
By Jeremy Lasich
Steven Schiff and Bruce Gluckman, faculty members in the Krasnow Institute for Advanced Study, and professors of psychology and physics respectively, have been awarded an additional patent covering treatment of seizures for those who suffer from epilepsy and Parkinson’s disease.
Previously, Schiff and Gluckman had been awarded a U.S. patent covering the method of treatment, and a Taiwanese patent on the invention. The newest patent, “Adaptive Electronic Field Modulation of Neural Systems,” covers the actual hardware device that monitors brain waves and controls abnormal activity with continuous and adaptive feedback stimulation.
Current hardware devices use intermittent feedback to monitor the brain for seizures, but Schiff’s and Gluckman’s invention will continuously keep track of the brain’s activity and suppress abnormal behavior before it reaches its peak. Such a method is more sensitive and allows a more precise and individualized strategy to control seizures than present approaches.
Schiff says they are performing safety, materials, and algorithm tests over the next couple of years. After that time, they expect the technology may be ready for human testing. For more information on the pair’s work with seizures and their first patent, “Adaptive Field Control of Epileptic Seizures,” click here.
The award of this patent to George Mason brings the number of total patents awarded to the university to 20.